Market by Gender, Indications, Treatment Type, Sales Channel, and Country | Forecast 2021-2028
The North America hair loss
treatment market is expected to progress in the forecast years from 2021 to
2028, while growing with a CAGR of 4.91%.
Report scope can be customized per your requirements. Request For Customization
The countries examined in this
market include:
• The United States
• Canada
A rising number of hair loss
cases are being seen in both men and women in the United States. Data from the
International Society of Hair Restoration Surgery suggests that nearly 35
million men and 21 million women in the country are affected by some type of
hair loss. Even among children, hair loss problems are on the rise. As per the
American Hair Loss Association, hair loss in children is responsible for
approx. 3% of all pediatric office visits in the US. This has led to an
increase in the demand for hair loss treatment.
Further, cases of obesity and stress
levels are also increasing in the United States. These conditions largely lead
to hair loss, which, in turn, is further augmenting the demand for its
treatment. This is fueling the market growth in the US, and the high disposable
income and the rise in consumer spending on grooming products are enabling this
growth. In addition, there are several pharmaceutical companies and charitable
organizations working on developing effective alopecia treatment. This is
another factor contributing to the US hair loss treatment market’s development.
Lexington
International LLC is a US-based company that manufactures and develops advanced
phototherapy medical devices for home use. It also provides the most advanced
hair loss treatments and hair care products. HairMax LaserComb is an
FDA-approved phototherapy medical device developed by the company for home use
to treat androgenetic alopecia and stimulate hair growth in individuals
affected by certain classes of hereditary hair loss. Whereas, PowerFlex Laser Cap
272 - The PowerFlex Laser Cap 272 helps
restore the hair’s natural growth cycle, thus resulting in new hair growth.
Founded in 2000, Lexington International is headquartered in Boca Raton,
Florida.
1. NORTH
AMERICA HAIR LOSS TREATMENT MARKET – SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
OF COVID-19 ON THE HAIR LOSS TREATMENT INDUSTRY
2.2. KEY
INSIGHTS
2.2.1. EFFORTS
TO DEVELOP STEM CELL HAIR TRANSPLANTATION METHOD
2.2.2. DEVELOPMENT
OF ROBOT HAIR RESTORATION SYSTEM
2.2.3. INTENSIVE
RESEARCH ON 3D PRINTING TECHNOLOGY FOR HAIR
2.3. PORTER’S
FIVE FORCES ANALYSIS
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTE
2.3.3. BARGAINING
POWER OF BUYERS
2.3.4. BARGAINING
POWER OF SUPPLIERS
2.3.5. THREAT
OF COMPETITIVE RIVALRY
2.4. MARKET
ATTRACTIVENESS INDEX
2.5. VENDOR
SCORECARD
2.6. KEY
MARKET STRATEGIES
2.6.1. ACQUISITIONS
2.6.2. PRODUCT
DEVELOPMENTS
2.6.3. CONTRACTS
& AGREEMENTS
2.6.4. INVESTMENT
& EXPANSIONS
2.7. MARKET
DRIVERS
2.7.1. RISE
IN CASES OF AUTOIMMUNE DISEASE
2.7.2. HIGH
CONSUMPTION OF ALCOHOL AND TOBACCO
2.7.3. UNHEALTHY
DIETARY HABITS
2.7.4. STRESS
AND CHANGING LIFESTYLES
2.8. MARKET
CHALLENGES
2.8.1. RISK
OF INFECTION OR SIDE EFFECTS
2.8.2. HIGH
COST OF TREATMENT
2.9. MARKET
OPPORTUNITIES
2.9.1. R&D
IN HAIR CLONING TECHNOLOGY
2.9.2. DEVELOPMENT
OF BARICITINIB
3. NORTH
AMERICA HAIR LOSS TREATMENT MARKET OUTLOOK – BY GENDER
3.1. FEMALE
3.2. MALE
4. NORTH
AMERICA HAIR LOSS TREATMENT MARKET OUTLOOK – BY INDICATIONS
4.1. ANDROGENIC
ALOPECIA
4.2. ALOPECIA
AREATA
4.3. ALOPECIA
TOTALIS
4.4. OTHER
INDICATIONS
5. NORTH
AMERICA HAIR LOSS TREATMENT MARKET OUTLOOK – BY TREATMENT TYPE
5.1. TOPICAL
HAIR LOSS TREATMENT,
5.1.1. MINOXIDIL
5.1.2. SHAMPOOS
5.2. ORAL
HAIR LOSS TREATMENT
5.2.1. FINASTERIDE
5.2.2. OTHER
ORAL HAIR LOSS TREATMENT
5.3. OTHER
TREATMENT TYPES
6. NORTH
AMERICA HAIR LOSS TREATMENT MARKET OUTLOOK – BY SALES CHANNEL
6.1. DRUG
STORES & RETAIL PHARMACIES
6.2. HOSPITAL
PHARMACIES
6.3. ONLINE
PHARMACIES
7. NORTH
AMERICA HAIR LOSS TREATMENT MARKET – REGIONAL OUTLOOK
7.1. UNITED
STATES
7.2. CANADA
8. COMPETITIVE
LANDSCAPE
8.1. TEVA
PHARMACEUTICALS
8.2. MERCK
& CO
8.3. CIPLA
LIMITED
8.4. JOHNSON
& JOHNSON
8.5. SUN
PHARMACEUTICAL INDUSTRIES LTD
8.6. CONCERT
PHARMACEUTICALS INC
8.7. SHISEIDO
COMPANY LIMITED
8.8. TAISHO
PHARMACEUTICAL CO LTD
8.9. DR
REDDYS LABORATORIES
8.10. THE
HIMALAYA DRUG COMPANY
8.11. TRANSITIONS
HAIR PVT LTD
8.12. LEXINGTON
INTERNATIONAL LLC
8.13. ACLARIS
THERAPEUTICS
8.14. CELLMID
8.15. DAIICHI
SANKYO
9. RESEARCH
METHODOLOGY & SCOPE
9.1. RESEARCH
SCOPE & DELIVERABLES
9.2. SOURCES
OF DATA
9.3. RESEARCH
METHODOLOGY
TABLE 1: NORTH AMERICA HAIR
LOSS TREATMENT MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: LIST OF ACQUISITIONS
TABLE 4: LIST OF PRODUCT
DEVELOPMENTS
TABLE 5: LIST OF CONTRACTS
& AGREEMENTS
TABLE 6: LIST OF INVESTMENT
& EXPANSIONS
TABLE 7: NORTH AMERICA HAIR
LOSS TREATMENT MARKET, BY GENDER, 2021-2028 (IN $ MILLION)
TABLE 8: NORTH AMERICA HAIR
LOSS TREATMENT MARKET, BY INDICATION, 2021-2028 (IN $ MILLION)
TABLE 9: NORTH AMERICA HAIR
LOSS TREATMENT MARKET, BY TREATMENT TYPE, 2021-2028 (IN $ MILLION)
TABLE 10: NORTH AMERICA HAIR
LOSS TREATMENT MARKET, BY TOPICAL (TREATMENT) TYPE, 2021-2028 (IN $ MILLION)
TABLE 11: NORTH AMERICA HAIR
LOSS TREATMENT MARKET, BY ORAL (TREATMENT) TYPE, 2021-2028 (IN $ MILLION)
TABLE 12: NORTH AMERICA HAIR
LOSS TREATMENT MARKET, BY SALES CHANNEL, 2021-2028 (IN $ MILLION)
TABLE 13: NORTH AMERICA HAIR
LOSS TREATMENT MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
FIGURE 1: MARKET
ATTRACTIVENESS INDEX
FIGURE 2: PREVALENCE OF
DIAGNOSED AUTOIMMUNE CONDITIONS IN SELECTED COUNTRIES IN 2019
FIGURE 3: NORTH AMERICA HAIR
LOSS TREATMENT MARKET, BY GENDER, 2020 & 2028 (IN %)
FIGURE 4: NORTH AMERICA HAIR
LOSS TREATMENT MARKET, BY FEMALE, 2021-2028 (IN $ MILLION)
FIGURE 5: NORTH AMERICA HAIR
LOSS TREATMENT MARKET, BY MALE, 2021-2028 (IN $ MILLION)
FIGURE 6: NORTH AMERICA HAIR
LOSS TREATMENT MARKET, BY INDICATIONS, 2020 & 2028 (IN %)
FIGURE 7: NORTH AMERICA HAIR
LOSS TREATMENT MARKET, BY ANDROGENIC ALOPECIA, 2021-2028 (IN $ MILLION)
FIGURE 8: NORTH AMERICA HAIR
LOSS TREATMENT MARKET, BY ALOPECIA AREATA, 2021-2028 (IN $ MILLION)
FIGURE 9: NORTH AMERICA HAIR
LOSS TREATMENT MARKET, BY ALOPECIA TOTALIS, 2021-2028 (IN $ MILLION)
FIGURE 10: NORTH AMERICA HAIR
LOSS TREATMENT MARKET, BY OTHER INDICATIONS, 2021-2028 (IN $ MILLION)
FIGURE 11: NORTH AMERICA HAIR
LOSS TREATMENT MARKET, BY TREATMENT TYPE, 2020 & 2028 (IN %)
FIGURE 12: NORTH AMERICA HAIR
LOSS TREATMENT MARKET, BY TOPICAL HAIR LOSS TREATMENT, 2020 & 2028 (IN %)
FIGURE 13: NORTH AMERICA HAIR
LOSS TREATMENT MARKET, BY TOPICAL, 2021-2028 (IN $ MILLION)
FIGURE 14: NORTH AMERICA HAIR
LOSS TREATMENT MARKET, BY MINOXIDIL, 2021-2028 (IN $ MILLION)
FIGURE 15: NORTH AMERICA HAIR
LOSS TREATMENT MARKET, BY SHAMPOOS, 2021-2028 (IN $ MILLION)
FIGURE 16: NORTH AMERICA HAIR
LOSS TREATMENT MARKET, BY ORAL HAIR LOSS TREATMENT, 2020 & 2028 (IN %)
FIGURE 17: NORTH AMERICA HAIR
LOSS TREATMENT MARKET, BY ORAL, 2021-2028 (IN $ MILLION)
FIGURE 18: NORTH AMERICA HAIR
LOSS TREATMENT MARKET, BY FINASTERIDE, 2021-2028 (IN $ MILLION)
FIGURE 19: NORTH AMERICA HAIR
LOSS TREATMENT MARKET, BY OTHER ORAL HAIR LOSS TREATMENT, 2021-2028 (IN $ MILLION)
FIGURE 20: NORTH AMERICA HAIR
LOSS TREATMENT MARKET, BY OTHER TREATMENT TYPES, 2021-2028 (IN $ MILLION)
FIGURE 21: NORTH AMERICA HAIR
LOSS TREATMENT MARKET, BY SALES CHANNEL, 2020 & 2028 (IN %)
FIGURE 22: NORTH AMERICA HAIR
LOSS TREATMENT MARKET, BY DRUG STORES & RETAIL PHARMACIES, 2021-2028 (IN $ MILLION)
FIGURE 23: NORTH AMERICA HAIR
LOSS TREATMENT MARKET, BY HOSPITAL PHARMACIES, 2021-2028 (IN $ MILLION)
FIGURE 24: NORTH AMERICA HAIR
LOSS TREATMENT MARKET, BY ONLINE PHARMACIES, 2021-2028 (IN $ MILLION)
FIGURE 25: NORTH AMERICA HAIR
LOSS TREATMENT MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)
FIGURE 26: UNITED STATES HAIR
LOSS TREATMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 27: CANADA HAIR LOSS
TREATMENT MARKET 2021-2028 (IN $ MILLION)